Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Prostate Cancer

  Free Subscription


19.03.2018

1 AJR Am J Roentgenol
1 Anticancer Res
25 BJU Int
2 BMC Cancer
2 Cancer Lett
1 Cancer Res
1 Eur J Radiol
2 Eur Urol
1 Int J Cancer
3 Int J Radiat Oncol Biol Phys
1 J Natl Cancer Inst
1 J Nucl Med
5 J Urol
1 Nat Rev Urol
1 Oncol Rep
3 Prostate
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. TANEJA S, Jena A, Taneja R, Singh A, et al
    Effect of Combined (68)Ga-PSMAHBED-CC Uptake Pattern and Multiparametric MRI Derived With Simultaneous PET/MRI in the Diagnosis of Primary Prostate Cancer: Initial Experience.
    AJR Am J Roentgenol. 2018 Mar 12:1-8. doi: 10.2214/AJR.17.18881.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. HOLMBERG AR, Marquez M, Lennartsson L, Meurling L, et al
    Synthesis and Binding of a Novel PSMA-specific Conjugate.
    Anticancer Res. 2018;38:1531-1537.
    PubMed     Text format     Abstract available


    BJU Int

  3. PATEL VR, Sandri M, Grasso AAC, De Lorenzis E, et al
    A novel tool for predicting extracapsular extension during graded partial nerve sparing in radical prostatectomy.
    BJU Int. 2018;121:373-382.
    PubMed     Text format     Abstract available

  4. EPSTEIN JI
    Central pathology review of radical prostatectomy specimens does make a difference not only with grade.
    BJU Int. 2017;120.
    PubMed     Text format    

  5. DASGUPTA P
    NICE guidance and the BJUI.
    BJU Int. 2017;120:743.
    PubMed     Text format    

  6. BJURLIN MA, Taneja SS
    Novel risk stratification nomograms for counseling patients on the need for prostate biopsy.
    BJU Int. 2017;120:746-747.
    PubMed     Text format    

  7. SATHIANATHEN NJ, Christidis D, Konety BR, Lawrentschuk NL, et al
    Magnetic resonance imaging cognitive fusion biopsy - is near enough good enough?
    BJU Int. 2018;121:324-326.
    PubMed     Text format    

  8. FLETCHER SA, Berg S, Trinh QD
    The new frontier of prostate biopsy: determining the role of image-guidance in moving the needle.
    BJU Int. 2018;121:4-5.
    PubMed     Text format    

  9. HEIDENREICH A, Pfister D
    Even 'low-dose' cabazitaxel requires careful and meticulous patient selection.
    BJU Int. 2018;121:163-164.
    PubMed     Text format    

  10. PALAYAPALAYAM GANAPATHI H, Onol F, Rogers T, Patel V, et al
    Nerve wrapping with biomaterials during radical prostatectomy to improve potency recovery.
    BJU Int. 2018;121:322-323.
    PubMed     Text format    

  11. GHANEM S, Namdarian B, Challacombe B
    To drain or not to drain after robot-assisted radical prostatectomy? That is the question.
    BJU Int. 2018;121:321-322.
    PubMed     Text format    

  12. RUSSO GI, Bier S, Hennenlotter J, Beger G, et al
    Expression of tumour progression-associated genes in circulating tumour cells of patients at different stages of prostate cancer.
    BJU Int. 2018 Mar 15. doi: 10.1111/bju.14200.
    PubMed     Text format     Abstract available

  13. CHENAM A, Yuh B, Zhumkhawala A, Ruel N, et al
    Prospective randomised non-inferiority trial of pelvic drain placement vs no pelvic drain placement after robot-assisted radical prostatectomy.
    BJU Int. 2018;121:357-364.
    PubMed     Text format     Abstract available

  14. SUARDI N, Montorsi F
    Salvage lymph node dissection: if yes, robotics?
    BJU Int. 2017;120:304-305.
    PubMed     Text format    

  15. GETTMAN MT
    Rethinking cancer surveillance with shared-care models and survivorship plans: the time is now!
    BJU Int. 2017;119:360-361.
    PubMed     Text format    

  16. DAVIS JW, MacLennan G
    The BJUI's clinical trials initiative.
    BJU Int. 2017;119:503.
    PubMed     Text format    

  17. MCGRATH S, Christidis D, Clarebrough E, Ingle R, et al
    Transperineal prostate biopsy - tips for analgesia.
    BJU Int. 2017;120:164-167.
    PubMed     Text format    

  18. FRYDENBERG M
    Reliability of negative multiparametric MRI of the prostate: can we avoid the biopsy? Not yet!
    BJU Int. 2017;119:E9-E10.
    PubMed     Text format    

  19. FICARRA V, Novara G, Dasgupta P
    Robot-assisted vs open radical prostatectomy: the day after.
    BJU Int. 2017;120:308-309.
    PubMed     Text format    

  20. CAVALLO JA, Tewari AK
    Somatic-autonomic neurorrhaphy for erectile function restoration after radical prostatectomy.
    BJU Int. 2017;119:816-818.
    PubMed     Text format    

  21. PORPIGLIA F, Bertolo R, Fiori C, Manfredi M, et al
    Chitosan membranes applied on the prostatic neurovascular bundles after nerve-sparing robot-assisted radical prostatectomy: a phase II study.
    BJU Int. 2018;121:472-478.
    PubMed     Text format     Abstract available

  22. MAI Z, Xiao Y, Yan W, Zhou Y, et al
    Comparison of lesions detected and undetected by template-guided transperineal saturation prostate biopsy.
    BJU Int. 2018;121:415-420.
    PubMed     Text format     Abstract available

  23. AUFFENBERG GB, Qi J, Gao Y, Miller DC, et al
    Evaluation of a needle disinfectant technique to reduce infection-related hospitalisation after transrectal prostate biopsy.
    BJU Int. 2018;121:232-238.
    PubMed     Text format     Abstract available

  24. KENIGSBERG AP, Tamada T, Rosenkrantz AB, Llukani E, et al
    Multiparametric magnetic resonance imaging identifies significant apical prostate cancers.
    BJU Int. 2018;121:239-243.
    PubMed     Text format     Abstract available

  25. AUBERTIN K, Trinh VQ, Jermyn M, Baksic P, et al
    Mesoscopic characterization of prostate cancer using Raman spectroscopy: Potential for diagnostics and therapeutics.
    BJU Int. 2018 Mar 15. doi: 10.1111/bju.14199.
    PubMed     Text format     Abstract available

  26. STONE N
    Low dose rate prostate brachytherapy in younger men.
    BJU Int. 2018;121:2.
    PubMed     Text format    

  27. LOEB S, Stork B, Gold HT, Stout NK, et al
    Tweet this: how advocacy for breast and prostate cancers stacks up on social media.
    BJU Int. 2017;120:461-463.
    PubMed     Text format    


    BMC Cancer

  28. KIM M, Song C, Jeong IG, Choi SK, et al
    Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.
    BMC Cancer. 2018;18:271.
    PubMed     Text format     Abstract available

  29. LIANG W, Song L, Peng Z, Zou Y, et al
    Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis.
    BMC Cancer. 2018;18:279.
    PubMed     Text format     Abstract available


    Cancer Lett

  30. OING C, Tennstedt P, Simon R, Volquardsen J, et al
    BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy.
    Cancer Lett. 2018 Mar 8. pii: S0304-3835(18)30196.
    PubMed     Text format     Abstract available

  31. UTTER M, Chakraborty S, Goren L, Feuser L, et al
    Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes.
    Cancer Lett. 2018;423:28-35.
    PubMed     Text format     Abstract available


    Cancer Res

  32. YU G, Cheng CJ, Lin SC, Lee YC, et al
    Organelle-derived acetyl-CoA promotes prostate cancer cell survival, migration, and metastasis via activation of calmodulin kinase II.
    Cancer Res. 2018 Mar 13. pii: 0008-5472.CAN-17-2392.
    PubMed     Text format     Abstract available


    Eur J Radiol

  33. BENNDORF M, Hahn F, Kronig M, Jilg CA, et al
    Diagnostic performance and reproducibility of T2w based and diffusion weighted imaging (DWI) based PI-RADSv2 lexicon descriptors for prostate MRI.
    Eur J Radiol. 2017;93:9-15.
    PubMed     Text format     Abstract available


    Eur Urol

  34. MONTGOMERY B, Lin DW
    Adjuvant Chemotherapy for Prostate Cancer: The Long and Winding Road.
    Eur Urol. 2018 Mar 8. pii: S0302-2838(18)30164.
    PubMed     Text format    

  35. DAVIS ID
    Answering Questions and Questioning Answers: More Evidence To Guide Decision-making About Chemohormonal Therapy in Metastatic Prostate Cancer.
    Eur Urol. 2018 Mar 7. pii: S0302-2838(18)30163.
    PubMed     Text format    


    Int J Cancer

  36. PORRETTI J, Dalton GN, Massillo C, Scalise GD, et al
    CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease.
    Int J Cancer. 2018 Mar 14. doi: 10.1002/ijc.31379.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  37. AKSNESSAETHER BY, Solberg A, Klepp OH, Myklebust TA, et al
    Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?
    Int J Radiat Oncol Biol Phys. 2018 Feb 5. pii: S0360-3016(18)30220.
    PubMed     Text format     Abstract available

  38. KEALL PJ, Colvill E, O'Brien R, Caillet V, et al
    Electromagnetic-Guided MLC Tracking Radiation Therapy for Prostate Cancer Patients: Prospective Clinical Trial Results.
    Int J Radiat Oncol Biol Phys. 2018 Feb 6. pii: S0360-3016(18)30222.
    PubMed     Text format     Abstract available

  39. SIVA S
    Prostate-Specific Membrane Antigen PET Before Aggressive Local Therapy to the Sternum.
    Int J Radiat Oncol Biol Phys. 2017;98:494-495.
    PubMed     Text format    


    J Natl Cancer Inst

  40. UNGER JM, Hershman DL, Till C, Tangen CM, et al
    Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.
    J Natl Cancer Inst. 2018 Mar 9. pii: 4925555. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Nucl Med

  41. PARENT EE, Schuster DM
    Update on (18)F-fluciclovine PET for prostate cancer imaging.
    J Nucl Med. 2018 Mar 9. pii: jnumed.117.204032. doi: 10.2967/jnumed.117.204032.
    PubMed     Text format     Abstract available


    J Urol

  42. KLOTZ L, Loblaw A, Siemens R, Ouellette P, et al
    A phase II, randomized, multicentre study comparing 10 months versus 4 months of degarelix (Firmagon(R)) therapy in prolonging the off treatment interval in men with localized prostate cancer receiving intermittent androgen deprivation therapy for bio
    J Urol. 2018 Mar 10. pii: S0022-5347(18)42502-5. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available

  43. SEFTEL AD
    Re: Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
    J Urol. 2017;197:1266.
    PubMed     Text format    

  44. RANDALL S, Boyd J, Fuller E, Brooks C, et al
    The effect of vasectomy reversal on prostate cancer risk: International meta-analysis of 684,660 men with vasectomies.
    J Urol. 2018 Mar 7. pii: S0022-5347(18)42489-5. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available

  45. TANEJA SS
    Re: Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
    J Urol. 2017;197:1265-1266.
    PubMed     Text format    

  46. TANEJA SS
    Re: Development and Validation of a 24-Gene Predictor of Response to Postoperative Radiotherapy in Prostate Cancer: A Matched, Retrospective Analysis.
    J Urol. 2017;197:1264-1266.
    PubMed     Text format    


    Nat Rev Urol

  47. THOMA C
    Prostate cancer: Enhancing VTP.
    Nat Rev Urol. 2018 Mar 13. pii: nrurol.2018.32. doi: 10.1038/nrurol.2018.
    PubMed     Text format    


    Oncol Rep

  48. CHEN Q, Zhu L, Zong H, Song X, et al
    Subcellular localization of aquaporin 3 in prostate cancer is regulated by RalA.
    Oncol Rep. 2018 Mar 9. doi: 10.3892/or.2018.6308.
    PubMed     Text format     Abstract available


    Prostate

  49. CHEN J, Oromendia C, Halpern JA, Ballman KV, et al
    National trends in management of localized prostate cancer: A population based analysis 2004-2013.
    Prostate. 2018 Mar 14. doi: 10.1002/pros.23496.
    PubMed     Text format     Abstract available

  50. DAVID SN, Arnold Egloff SA, Goyal R, Clark PE, et al
    MAGI2 is an independent predictor of biochemical recurrence in prostate cancer.
    Prostate. 2018 Mar 14. doi: 10.1002/pros.23506.
    PubMed     Text format     Abstract available

  51. WANG Y, Xu H, Si L, Li Q, et al
    MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11.
    Prostate. 2018 Mar 14. doi: 10.1002/pros.23468.
    PubMed     Text format     Abstract available


    Urology

  52. ZARGAR-SHOSHTARI K, Lawrentschuk N, Zargar H
    Robotic Prostatectomy Delivers on the Promise of Minimally Invasive Surgery: Commentary on: Robot-assisted Laparoscopic Prostatectomy Versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study.
    Urology. 2017;99:3-4.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: